TODAY'S HEADLINES

Will Trump's FDA picks speed drug approvals?

Three candidates whom President Trump is considering for FDA commissioner are likely to speed drug approvals, analysts say. Find out why

First therapy approved for rare blood cancer

FDA granted accelerated approval for ibrutinib (Imbruvica), the first treatment for patients with a certain type of lymphoma. Read more

CONTINUING PHARMACY EDUCATION

New options when statins are not enough

This month's CE activity, "New options when statins are not enough," is open for pharmacists and pharmacy technicians.
The goal of this activity is to prepare pharmacists with the knowledge they need to have to provide contemporary pharmacologic therapy to patients with hyperlipidemia.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

New 340B rule sets drugmaker fines

Consumer health groups are praising HHS' new rule on the Medicaid 340B drug discount program, which sets a ceiling on drug prices. Read more

February 1, 2017

Managed Care Pharmacy Survey 2017

Take three minutes to answer our managed care pharmacy survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards. Take survey.

Related Articles

Trump's drug pricing comments create debate

Breakthrough lymphoma drug on horizon